 platelet aggregate formation patients chronic airflow obstruction hypoxaemia Platelet aggregate formation vivo means platelet ratio platelet release products beta thromboglobulin platelet factor thromboxane patients chronic airflow obstruction hypoxaemia control subjects respiratory disease hypoxaemic patients long term oxygen therapy platelet aggregate ratio hypoxaemic patients SE non-hypoxaemic control groups trend aggregate ratios hypoxaemic patients Platelet release products peripheral venous blood patients control subjects behaviour chronic hypoxaemia enhanced platelet activity pulmonary vascular damage patients direct effects mediator release